Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.05
Last update: Aug 14, 9:20 AM
ADC Therapeutics SA
ADCTNYSE
PRO
Earnings: Q2 2026 Earnings were released on Thu Aug 13th, before the market open
Conference Call: The most recent conference call started at 8:30 AM, 1 day agoClick to view the webcast
ADC Therapeutics Market Sentiment
Market sentiment signals for ADC Therapeutics (ADCT): analyst consensus, short interest, options flow and insider activity.
Key Signals
Analyst Consensus▲ Buy
Short Interest▲ 4.7% short float
Options Flow▲ 0.00 P/C ratio
Insider Activity— N/A
Analyst Consensus
Buy
7 analysts
Options Flow (P/C)
0.00
More calls — Bullish
2 calls · 0 puts
Avg Consensus PT
$7
+566.7%
Highest Price Target
$10
+852.4%
Guggenheim
Lowest Price Target
$2
+90.5%
RBC Capital
Short Interest
4.7%
Declining — Bullish
Insider Activity (30d)
—
Short Interest — % of Float
Recent Analyst Actions
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Jun 8, 2026 | HC Wainwright & Co. | Robert Burns— | — | — | Downgrade | Buy→Neutral |
| Jun 4, 2026 | RBC Capital | Leonid Timashev— | +90.5% | $6 → $2 | Downgrade | Outperform→Sector Perform |
